StockData
Medline Inc. logo

Medline Inc.

MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 2/3060% above fair value
$37.04−0.80 (-2.11%)

Close on Nov 20, 2026Market cap $48.70BP/E –Yield –

Medline EBITDA Adjustment by Quarter

EBITDA Adjustment — Non-Cash LIFO & Inventory Step-Up ($M)

Medline EBITDA Adjustment: $122M in Q3 2026, up 6,000.0% from a year earlier.

Latest, Q3 2026
122
Period ended Sep 30, 2026
Change on a year earlier
+6,000.0%
2 in Q3 2025
History
7 quarters
Since Q1 2025
Sources
4
Documents cited below

Where the Q3 2026 figure comes from

Source: SEC Form 10-Q (FY2026Q3, filed 2026-11-04) ↗

Reported in SEC Form 10-K & Form 10-Q Segment Footnotes (XBRL).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEBITDA Adjustment — Non-Cash LIFO & Inventory Step-Up ($M)Year on yearSource
Q3 2026Sep 30, 2026122+6,000.0%SEC Form 10-Q (FY2026Q3, filed 2026-11-04) ↗
Q2 2026Jun 30, 20263-80.0%SEC Form 10-Q (FY2026Q2, filed 2026-08-05) ↗
Q1 2026Mar 31, 202629+38.1%SEC Form 10-Q (FY2026Q1, filed 2026-05-06) ↗
Q4 2025Dec 31, 202545–SEC Form 10-K FY2025 (filed 2026-03-04) ↗
Q3 2025Sep 30, 20252–SEC Form 10-Q (FY2026Q3, filed 2026-11-04) ↗
Q2 2025Jun 30, 202515–SEC Form 10-Q (FY2026Q2, filed 2026-08-05) ↗
Q1 2025Mar 31, 202521–SEC Form 10-Q (FY2026Q1, filed 2026-05-06) ↗

Cite this data

StockData. (2026). Medline EBITDA Adjustment ($M), quarterly Q1 2025–Q3 2026 [Data set]. Compiled from Medline SEC filings and investor materials. https://stockdatahq.com/stocks/mdln/kpis/ng-adj-inventory

See every metric in the Medline KPI table. Data updated Nov 7, 2026.

See a number that looks wrong?